Back to News
Market Impact: 0.35
TGTX Stock Rises 60% in 6 Months: Here's What You Should Know
Source: zacks.com
Healthcare & BiotechCorporate Guidance & OutlookCompany FundamentalsProduct Launches
TG Therapeutics shares climbed 59.9% over six months, supported by strong uptake of Briumvi, higher 2026 revenue guidance, and studies exploring additional indications. The article provides no revenue figures or details on the guidance increase.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
moderately positive
Sentiment Score
0.55
Ticker Sentiment
TGTX0.75
More News
- South Korean carmaker Hyundai plans 'strategic' investment of $15.5 billion in India by 2032
- Applied Materials’ $5 billion AI lab aims to cut chip development time in half—and restore Silicon Valley’s edge
- Wells Fargo CFO on Earnings, Deals, Consumer Strength
- Bank of America hit with more than $1.2 billion in penalties over money-laundering violations
- Meta’s Muse models reach the AI frontier—and kill any hopes to ‘pace’ it
- Mainspring, AEP Strike Deal to Bring Power Online Faster